Strategic investments, workforce readiness, and pioneering initiatives are attracting leading life sciences companies to ...

A major pharmaceutical company that has invested heavily in North Carolina is ... Elsewhere in the state, Eli Lilly has invested heavily in a manufacturing campus in Concord.

Eli Lilly has announced plans to expand its ... investments in locations such as Research Triangle Park and Concord in North Carolina, updates to several Indianapolis facilities, the LEAP ...

Eli Lilly has also said that a new plant in Concord, North Carolina, will start production of incretin drugs as early as the end of the year, with products available to ship in 2025. The company ...

Eli Lilly and Company has announced plans to bolster its domestic ... New sites in Research Triangle Park and Concord, North Carolina New sites at the LEAP Innovation District in Lebanon, Indiana ...

Eli Lilly has raised its revenue guidance ... In its update, Ricks said a new facility at Concord in North Carolina – part of an $18 billion investment programme launched in 2020 – is being ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans ... announced new sites at Research Triangle Park in Concord, North Carolina, and the acquisition and expansion of its ...